Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive decline.

van den Kommer TN, Dik MG, Comijs HC, Lütjohann D, Lips P, Jonker C, Deeg DJ.

Neurobiol Aging. 2012 Mar;33(3):622.e17-28. doi: 10.1016/j.neurobiolaging.2011.02.019. Epub 2011 Apr 11.

2.

Total cholesterol and oxysterols: early markers for cognitive decline in elderly?

van den Kommer TN, Dik MG, Comijs HC, Fassbender K, Lütjohann D, Jonker C.

Neurobiol Aging. 2009 Apr;30(4):534-45. Epub 2007 Sep 20. Erratum in: Neurobiol Aging. 2011 Sep;32(9):1730.

PMID:
17888546
3.

APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.

Schiepers OJ, Harris SE, Gow AJ, Pattie A, Brett CE, Starr JM, Deary IJ.

Mol Psychiatry. 2012 Mar;17(3):315-24. doi: 10.1038/mp.2010.137. Epub 2011 Jan 25.

PMID:
21263443
4.

Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.

Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C.

Stroke. 2000 Oct;31(10):2431-6.

5.

Salivary cortisol, APOE-ε4 allele and cognitive decline in a prospective study of older persons.

Gerritsen L, Comijs HC, Deeg DJ, Penninx BW, Geerlings MI.

Neurobiol Aging. 2011 Sep;32(9):1615-25. doi: 10.1016/j.neurobiolaging.2009.09.007. Epub 2009 Oct 30.

PMID:
19879666
6.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
7.

[Apolipoprotein E4 and memory decline in the elderly].

Jonker C, Dik MG, van Kamp GJ, Deeg DJ.

Tijdschr Gerontol Geriatr. 2000 Oct;31(5):198-202. Dutch.

PMID:
11064931
8.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991. Epub 2011 Jun 21.

PMID:
21701228
9.

Association between apolipoprotein E4 and cognitive decline in elderly adults.

Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C; Prospective Study of Pravastatin in the Elderly at Risk Group.

J Am Geriatr Soc. 2007 Nov;55(11):1777-85.

PMID:
17979899
10.

Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction.

Feng L, Li J, Yap KB, Kua EH, Ng TP.

Am J Clin Nutr. 2009 Apr;89(4):1263-8. doi: 10.3945/ajcn.2008.26969. Epub 2009 Feb 25.

11.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
12.

APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.

Niti M, Yap KB, Kua EH, Ng TP.

J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):306-11. doi: 10.1093/gerona/gln013. Epub 2009 Jan 30.

13.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
14.

Role of lipoproteins and inflammation in cognitive decline: do they interact?

van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJ.

Neurobiol Aging. 2012 Jan;33(1):196.e1-12. doi: 10.1016/j.neurobiolaging.2010.05.024. Epub 2010 Jul 1.

PMID:
20594617
15.

Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.

Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG.

Neurology. 2004 Jun 8;62(11):1990-5.

PMID:
15184602
16.

APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.

van Vliet P, Oleksik AM, Mooijaart SP, de Craen AJ, Westendorp RG.

Neurology. 2009 Mar 3;72(9):821-8. doi: 10.1212/01.wnl.0000343852.10018.24.

PMID:
19255409
17.

Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.

van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.

Psychol Med. 2009 Nov;39(11):1907-11. doi: 10.1017/S0033291709005492. Epub 2009 Apr 1.

PMID:
19335933
18.

Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.

Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.

J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30.

PMID:
19573495
19.

Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study.

Caselli RJ, Osborne D, Reiman EM, Hentz JG, Barbieri CJ, Saunders AM, Hardy J, Graff-Radford NR, Hall GR, Alexander GE.

J Neurol Sci. 2001 Aug 15;189(1-2):93-8.

PMID:
11535238
20.

Apolipoprotein E genotype and lifetime cognitive decline.

Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG.

Int Psychogeriatr. 2008 Feb;20(1):109-23. Epub 2007 Aug 22.

PMID:
17711604
Items per page

Supplemental Content

Write to the Help Desk